减少石头风险的非药理方法:饮食和补充剂
1Department of Urology, University of Wisconsin School of Medicine and Public Health, 1685 Highland Avenue, 3258 Medical Foundation Centennial Building, Madison, WI 53705-2281, USA.
The Urologic clinics of North America
|July 3, 2025
概括
这篇文章讨论了个性化,非药物治疗的策略,以减少结石风险. 它强调根据患者特定的尿路和饮食因素量身定制治疗方法,以有效管理尿病.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 代谢医学是一种代谢医学.
背景情况:
- 结石 (结石) 在个体之间表现出显著的异质性.
- 了解这种异质性对于有效管理至关重要.
- 常见的结石类型需要量身定制的降低风险的方法.
研究的目的:
- 为以患者为中心,非药物风险降低结石疾病提供背景和理由.
- 审查基于证据的策略,以解决尿路和饮食风险因素.
- 鼓励基于个性化评估的有针对性的非药物疗法.
主要方法:
- 审查有关尿病异质性的现有文献.
- 对非药物风险因素修改的基于证据的策略的分析.
- 强调以患者为中心的评估和个性化治疗规划.
主要成果:
- 尿病是高度可变的,需要个性化的方法.
- 证据支持针对尿路和饮食风险因素的非药物干预措施.
- 根据患者评估,有针对性的疗法是有效的.
结论:
- 对于常见的结石,建议以患者为中心,个性化,非药物风险降低.
- 通过量身定制的策略来解决特定的石质性风险因素是关键.
- 将患者特异性因素纳入治疗计划,可以改善尿病的管理.
相关概念视频
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
35
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
35
Urinary Tract Calculi III: Medical Management
28
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
28
Urinary Tract Calculi V: Nursing Management
33
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
33
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Urinary Tract Calculi I: Introduction
51
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
51
Urinary Tract Calculi VI: Surgical Management
35
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
35


